Duality Advisers, LP Ab Cellera Biologics Inc. Transaction History

Duality Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$4.29 - $5.97 $184,221 - $256,363	-42,942 Reduced 38.67%	68,099 $308,000
Q4 2023 Feb 01, 2024	SELL	$3.91 - $5.93 $200,031 - $303,372	-51,159 Reduced 31.54%	111,041 $634,000
Q3 2023 Nov 02, 2023	BUY	$4.6 - $7.95 $173,995 - $300,708	37,825 Added 30.41%	162,200 $746,000
Q2 2023 Jul 31, 2023	SELL	$5.66 - $7.59 $11,393 - $15,278	-2,013 Reduced 1.59%	124,375 $803,000
Q1 2023 Jun 27, 2023	BUY	$7.31 - $11.18 $923,896 - $1.41 Million	126,388 New	126,388 $952,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.